000 01327 a2200361 4500
005 20250514062511.0
264 0 _c20030411
008 200304s 0 0 eng d
022 _a0027-8874
024 7 _a10.1093/jnci/95.6.484
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSinger, Gad
245 0 0 _aMutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.
_h[electronic resource]
260 _bJournal of the National Cancer Institute
_cMar 2003
300 _a484-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aCodon
650 0 4 _aCystadenocarcinoma, Papillary
_xgenetics
650 0 4 _aFemale
650 0 4 _aGenes, ras
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aOvarian Neoplasms
_xgenetics
650 0 4 _aProto-Oncogene Proteins c-raf
_xgenetics
700 1 _aOldt, Robert
700 1 _aCohen, Yoram
700 1 _aWang, Brant G
700 1 _aSidransky, David
700 1 _aKurman, Robert J
700 1 _aShih, Ie-Ming
773 0 _tJournal of the National Cancer Institute
_gvol. 95
_gno. 6
_gp. 484-6
856 4 0 _uhttps://doi.org/10.1093/jnci/95.6.484
_zAvailable from publisher's website
999 _c12438684
_d12438684